Analyst Edward Nash from Canaccord Genuity maintained a Buy rating on Travere Therapeutics (TVTX – Research Report) and keeping the price ...
Canaccord Genuity analyst Edward Nash has maintained their bullish stance on TVTX stock, giving a Buy rating yesterday. Edward Nash has given ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback